In his most recent commentary on living on active surveillance, journalist Howard Wolinsky writes about the issue of anxiety which can affect a significant subset of men who are appropriate candidates for active surveillance (AS) or who have difficulty staying on AS — particularly during their first two years of management using this technique. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, anxiety, AS, surveillance | 3 Comments »
“Anxiety” of different types is a problem associated with every diagnosis of prostate cancer. Such anxiety comes with particular implications for men implementing active surveillance as an initial management strategy after initial diagnosis with very low-, low-, or favorable intermediate-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, anxiety, change, surveillance, time | 2 Comments »
According to a newly published paper in the Journal of Urology,
Emotional distress may motivate men with low risk prostate cancer to choose more aggressive treatment. Addressing emotional distress before and during treatment decision making may reduce a barrier to the uptake of active surveillance.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: anxiety, choice, decision-making, Diagnosis, emotion, risk, Treatment | 4 Comments »
There is some scientific literature that gets presented and published that makes one wonder, seriously, what is going on in the minds of the researchers — let alone in the minds of the people who agree to fund such research. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: anxiety, fear, recurrence | 3 Comments »
A small, randomized, pilot study has shown that music (along with some lidocaine) reduces the anxiety, pain, and dissatisfaction of men having a TRUS-guided biopsy compared to the lidocaine alone. … READ MORE …
Filed under: Diagnosis | Tagged: anxiety, biopsy, music, pain, satisfaction | 4 Comments »
A new study just published yesterday in the Journal of Clinical Oncology provides some interesting insights into the risk for various types of mental and emotional distress associated with diagnosis and treatment of cancer among > 2,100 patients with cancer interviewed according to a standardized protocol in Germany. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: anxiety, distress, mental health, prevalence | 1 Comment »
A group of medical students and fellows at Duke University have shown that if you distract patients’ attention while they are having a prostate biopsy it can (at least to some extent) reduce the likelihood of patient reports of pain and anxiety associated with the procedure. … READ MORE …
Filed under: Diagnosis | Tagged: anxiety, Bach, biopsy, Brandenberg, pain | 10 Comments »
A new paper in the European Journal of Cancer suggests that men with prostate cancer are at increased risk for depression, for post-traumatic stress disorder, and for use of antidepressant drugs compared to age-matched controls. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: anxiety, depression, post-traumatic stress disorder, risk, Sweden, Treatment | 3 Comments »
The potential of “natural products” as agents to prevent and/or treat prostate cancer (and other forms of cancer) is a topic of constant interest to many patients — even though the available data has demonstrated — at best — a limited effectiveness of almost all such products tested. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: anxiety, extract, mushroom, mycelium, PSA | 2 Comments »
A Dutch research group has published follow-up data related to their continuing evaluation of anxiety and distress levels among men with low-risk, loocalized prostate cancer who are managed with active surveillance at their institution. … READ MORE … >
Filed under: Living with Prostate Cancer, Management | Tagged: active surveillance, anxiety, distress | Leave a comment »
There has been good evidence that older cancer patients report less “distress” than younger cancer patients. However, there has been very little research to date into the distinctions among general distress, anxiety, and depression in aging prostate cancer patients. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: age, anxiety, depression, distress | Leave a comment »
One of the issues that worries people about active surveillance and other forms of “non-interventional” management for prostate cancer is whether patients will suffer unduly from anxiety and distress while living with “untreated” cancer. We know that there are patients who have been on such protocols long-term who do not; we also know that there are some patients who find the idea of living with “untreated” prostate cancer too difficult to deal with. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, anxiety, depression, distress | 6 Comments »
It is well known to readers of The “New” Prostate Cancer InfoLink that androgen deprivation therapy (ADT) is a commonly used form of treatment for patients who experience biochemical recurrence (BCR) after first- or second-line therapy. However, as is also well known, the optimal timing of ADT initiation is uncertain, and earlier initiation of ADT can cause toxicities that lower patients’ health-related quality of life (HRQOL). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation therapy, anxiety, hormone therapy, HRQOL, quality of life | 3 Comments »
Looking through my assorted notes from the meeting this morning after getting home late last night, there are four other poster presentations that are worth commenting on very specifically, and then a general comment that I would add. … READ MORE …
Filed under: Management, Treatment | Tagged: abiraterone, active surveillance, anxiety, cost, depression, MDV3100, radical prostatectomy | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 